Lopriore P, Palermo G, Meli A, Bellini G, Benevento E, Montano V
Mov Disord Clin Pract. 2024; 11(8):948-965.
PMID: 38943319
PMC: 11329577.
DOI: 10.1002/mdc3.14148.
Conti F, Di Martino S, Drago F, Bucolo C, Micale V, Montano V
Int J Mol Sci. 2023; 24(23).
PMID: 38069070
PMC: 10706469.
DOI: 10.3390/ijms242316746.
Finsterer J, Ghosh R
Clin Case Rep. 2023; 11(6):e7592.
PMID: 37351357
PMC: 10282112.
DOI: 10.1002/ccr3.7592.
Ripolone M, Zanotti S, Napoli L, Ronchi D, Ciscato P, Comi G
J Pers Med. 2023; 13(1).
PMID: 36675808
PMC: 9865457.
DOI: 10.3390/jpm13010147.
Finsterer J, Scorza F, Scorza C, Fiorini A
Clinics (Sao Paulo). 2021; 76:e2675.
PMID: 33567051
PMC: 7847250.
DOI: 10.6061/clinics/2021/e2675.
The molecular pathology of pathogenic mitochondrial tRNA variants.
Richter U, McFarland R, Taylor R, Pickett S
FEBS Lett. 2021; 595(8):1003-1024.
PMID: 33513266
PMC: 8600956.
DOI: 10.1002/1873-3468.14049.
Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial DNA.
Buneeva O, Fedchenko V, Kopylov A, Medvedev A
Biomedicines. 2020; 8(12).
PMID: 33321831
PMC: 7763033.
DOI: 10.3390/biomedicines8120591.
Muscle Biopsy: A Boon for Diagnosis of Mitochondrial Parkinsonism in Developing Countries.
Shree R, Mehta S, Goyal M, Gaspar B, Lal V
Ann Indian Acad Neurol. 2019; 22(2):228-230.
PMID: 31007443
PMC: 6472221.
DOI: 10.4103/aian.AIAN_436_17.
Brain Mitochondria, Aging, and Parkinson's Disease.
Rango M, Bresolin N
Genes (Basel). 2018; 9(5).
PMID: 29751692
PMC: 5977190.
DOI: 10.3390/genes9050250.
Movement disorders in mitochondrial disease.
Ghaoui R, Sue C
J Neurol. 2018; 265(5):1230-1240.
PMID: 29307008
DOI: 10.1007/s00415-017-8722-6.
Psoriasis, bulbar involvement, and diarrhea in late myoclonic epilepsy with ragged-red fibers-syndrome due to the m.8344A > G tRNA (Lys) mutation.
Finsterer J, Kovacs G
Iran J Neurol. 2017; 16(1):45-49.
PMID: 28717435
PMC: 5506757.
Ageing and Parkinson's disease: why is advancing age the biggest risk factor?.
Reeve A, Simcox E, Turnbull D
Ageing Res Rev. 2014; 14:19-30.
PMID: 24503004
PMC: 3989046.
DOI: 10.1016/j.arr.2014.01.004.
Tissue-specific implications of mitochondrial alterations in aging.
Liu D, Li H, Lu J, Bai Y
Front Biosci (Elite Ed). 2013; 5(2):734-47.
PMID: 23277028
PMC: 4706150.
DOI: 10.2741/e654.
The role of mitochondria in neurodegenerative diseases.
Filosto M, Scarpelli M, Cotelli M, Vielmi V, Todeschini A, Gregorelli V
J Neurol. 2011; 258(10):1763-74.
PMID: 21604203
DOI: 10.1007/s00415-011-6104-z.
Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?.
Clark J, Dai Y, Simon D
Parkinsons Dis. 2011; 2011:659694.
PMID: 21603185
PMC: 3096076.
DOI: 10.4061/2011/659694.
POLG1-related and other "mitochondrial Parkinsonisms": an overview.
Orsucci D, Caldarazzo Ienco E, Mancuso M, Siciliano G
J Mol Neurosci. 2011; 44(1):17-24.
PMID: 21221844
DOI: 10.1007/s12031-010-9488-9.
Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.
Simon D, Pankratz N, Kissell D, Pauciulo M, Halter C, Rudolph A
BMC Med Genet. 2010; 11:53.
PMID: 20356410
PMC: 2858137.
DOI: 10.1186/1471-2350-11-53.
A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes.
Zaganas I, Latsoudis H, Papadaki E, Vorgia P, Spilioti M, Plaitakis A
J Neurol. 2009; 256(2):271-3.
PMID: 19253012
DOI: 10.1007/s00415-009-0921-3.
Mitochondrial DNA sequence variation and neurodegeneration.
Mancuso M, Filosto M, Orsucci D, Siciliano G
Hum Genomics. 2009; 3(1):71-8.
PMID: 19129091
PMC: 3525185.
DOI: 10.1186/1479-7364-3-1-71.
How can we treat mitochondrial encephalomyopathies? Approaches to therapy.
Horvath R, Gorman G, Chinnery P
Neurotherapeutics. 2008; 5(4):558-68.
PMID: 19019307
PMC: 4514691.
DOI: 10.1016/j.nurt.2008.07.002.